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Ectodermal placodes, from which many cranial sense organs and ganglia develop, arise from a common placodal primordium defined by
Six1 expression. Here, we analyse placodal Six1 induction in Xenopus using microinjections and tissue grafts. We show that placodal Six1
induction occurs during neural plate and neural fold stages. Grafts of anterior neural plate but not grafts of cranial dorsolateral endomesoderm
induce Six1 ectopically in belly ectoderm, suggesting that only the neural plate is sufficient for inducing Six1 in ectoderm. However,
extirpation of either anterior neural plate or of cranial dorsolateral endomesoderm abolishes placodal Six1 expression indicating that both
tissues are required for its induction. Elevating BMP-levels blocks placodal Six1 induction, whereas ectopic sources of BMP inhibitors
expand placodal Six1 expression without inducing Six1 ectopically. This suggests that BMP inhibition is necessary but needs to cooperate
with additional factors for Six1 induction. We show that FGF8, which is expressed in the anterior neural plate, can strongly induce ectopic
Six1 in ventral ectoderm when combined with BMP inhibitors. In contrast, FGF8 knockdown abolishes placodal Six1 expression. This
suggests that FGF8 is necessary and together with BMP inhibitors sufficient to induce placodal Six1 expression in cranial ectoderm,
implicating FGF8 as a central component in generic placode induction.
D 2005 Elsevier Inc. All rights reserved.Keywords: Placodes; Neural crest; Neural plate; Ectodermal patterning; Six1; FGF8; BMP4; Pre-placodal regionIntroduction
Ectodermal placodes give rise or contribute to many
specialised sense organs of the vertebrate head (olfactory,
lens, otic, and lateral line placodes), some cranial sensory
ganglia (profundal, trigeminal, otic, lateral line, and
epibranchial placodes) as well as the pituitary (adenohypo-
physeal placode) (Webb and Noden, 1993; Northcutt, 1996;
Schlosser and Northcutt, 2000; Baker and Bronner-Fraser,
2001; Schlosser, 2002, 2005; Schlosser and Ahrens, 2004;
Streit, 2004). Because individual placodes require different
inducers and have distinct developmental fates, they were
traditionally thought to have independent developmental
origins (Stone, 1922; Northcutt and Bra¨ndle, 1995; Graham0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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ment are shared by all placodes (reviewed in Baker and
Bronner-Fraser, 2001; Schlosser, 2005). These include
reliance on cell shape changes (during invagination or
epithelial–mesenchymal transitions and cell migration) and
the generation of neurons in all except the adenohypophy-
seal and lens placode. Moreover, fate mapping studies in
different vertebrates indicate that all placodes originate
from a common crescent-shaped pre-placodal domain
immediately adjacent to the anterior neural plate and neural
crest (Vogt, 1929; Ro¨hlich, 1931; Carpenter, 1937; Fautrez,
1942; Keller, 1975; Couly and Le Douarin, 1987, 1990;
Eagleson and Harris, 1990; Eagleson et al., 1995; Kozlow-
ski et al., 1997; Streit, 2002, 2004; Bhattacharyya et al.,
2004).
Recently, it was shown that the transcription factors
Six1, Six4, and Eya1 are expressed in this pre-placodal
region (Oliver et al., 1995; Xu et al., 1997; Mishima and288 (2005) 40 – 59
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and Bovolenta, 1999; Sahly et al., 1999; Kobayashi et al.,
2000; Pandur and Moody, 2000; Ozaki et al., 2001;
Ghanbari et al., 2001; David et al., 2001; McLarren et al.,
2003; Laclef et al., 2003; Zheng et al., 2003; Li et al., 2003;
Schlosser and Ahrens, 2004; Bessarab et al., 2004;
Kozlowski et al., 2005). Subsequently, their expression is
maintained in all placodes (with the exception of the lens in
Xenopus) and their derivatives at least until tailbud stages
(Schlosser and Ahrens, 2004). The development of many
placodes, including trigeminal, profundal, otic, epibran-
chial, and olfactory placodes is perturbed in mouse and
zebrafish mutants of Six1 (Laclef et al., 2003; Zheng et al.,
2003; Li et al., 2003; Ozaki et al., 2004; Zou et al., 2004)
and Eya1 (Xu et al., 1999, 2002; Kozlowski et al., 2005;
Zou et al., 2004). Although other placodes appear relatively
normal in these mutants and Six4 mutants show no gross
placodal defects (Ozaki et al., 2001), this may be due to
functional redundancy with other Six and Eya genes
expressed in overlapping patterns. Six1 and Eya1 mutants
are mainly deficient in placodal size control (decreased
proliferation and increased apoptosis), morphogenesis (with
compromised invaginations and epithelial–mesenchymal
transitions), and neurogenesis suggesting that these genes
may be involved in the regulation of generic placodal
properties shared by different placodes (Streit, 2001;
Schlosser and Ahrens, 2004; Schlosser, 2005). Thus, the
expression of Six1 and Eya1 in the pre-placodal region at
neural plate stages has been proposed to define a
panplacodal primordium, i.e., a region of ectoderm with a
bias for generic placodal development (Baker and Bronner-
Fraser, 2001; Schlosser and Ahrens, 2004; Streit, 2004;
Schlosser, 2005).
The origin of all placodes from a common primordium
suggests that placode induction is a complex process
depending on both a generic inductive step for the
induction of panplacodally required genes such as Six1
and Eya1, and on specific inductive steps leading to the
locally restricted induction of particular placodes. Several
recent studies have begun to unravel how specific
placodes are induced (reviewed in Grainger, 1996; Ogino
and Yasuda, 2000; Baker and Bronner-Fraser, 2001; Scully
and Rosenfeld, 2002; Noramly and Grainger, 2002; Riley
and Phillips, 2003; Bhattacharyya and Bronner-Fraser,
2004), but the induction of the panplacodal primordium
itself is not well understood. However, its stereotypical
positioning relative to neural crest and neural plate
domains has led to suggestions that these three ectodermal
domains may rely on a common inductive mechanism,
e.g. autonomous temporal changes in ectodermal compe-
tence resulting in spatial differences of responses to a
common inducer diffusing from the dorsal midline
(Nieuwkoop et al., 1985; Albers, 1987), or different
responses at different threshold concentrations of a BMP
gradient during gastrulation (Sasai and De Robertis, 1997;
Neave et al., 1997; Nguyen et al., 1998; Marchant et al.,1998; Mayor and Aybar, 2001; Aybar and Mayor, 2002;
Tribulo et al., 2004; Glavic et al., 2004; Brugmann et al.,
2004).
Here, we use Six1 as a marker to elucidate, which tissues
and signals are involved in the generic step of placode
induction in Xenopus. We show that both the anterior
neural plate and the cranial dorsolateral endomesoderm are
necessary for placodal Six1 induction, but that only the
anterior neural plate can induce Six1 ectopically. Placodal
Six1 induction is blocked either by elevation of BMP levels
or by knockdown of FGF8, which is strongly expressed in
the anterior neural plate. This indicates that both BMP
inhibitors and FGF8 are required for Six1 induction.
Finally, we demonstrate that FGF8 strongly induces ectopic
Six1 when BMPs are inhibited, implicating FGF8 as a
central component in generic placode induction. However,
our findings do not provide support for the proposed role of
a BMP gradient in inducing and positioning generic
placodal markers.Materials and methods
Animals
Embryos of Xenopus laevis were obtained by hormone
induced egg laying followed by in vitro fertilisation and
staged according to Nieuwkoop and Faber (1967) as
described in Sive et al. (2000). Prior to fixation, tailbud
stage embryos were anesthetised in tricaine methane-
sulfonate (MS 222).
Microinjections
For microinjections, embryos were placed in 5% Ficoll
in 0.1 MBS (Sive et al., 2000) and transferred to 0.1
MBS after reaching blastula stages. Capped mRNAs were
synthesised from linearised plasmids (Ambion Message
Machine Kit) encoding myc-GFP (pCMTEGFP; kindly
provided by Doris Wedlich), noggin (pNogD5V-CS2+;
Eimon and Harland, 1999), a truncated BMP-receptor
(pSP64T-tBMPR; Graff et al., 1994), BMP4 (pGEM7-
xBMP4; Hemmati-Brivanlou and Thomsen, 1995), and
FGF8 (pCS2+XFGF8; Christen and Slack, 1997).
Embryos, which served as donors for tissue grafts, were
injected at the 2- or 4-cell stage into all blastomeres with
a total of 1 ng for each injected mRNA except for the
truncated BMP-receptor (2 ng). An FGF8 antisense
morpholino oligonucleotide (5V-CCAGGATGGAGGT-
GATGTAGTTCAT-3V) as well as a standard control morpho-
lino were obtained from GeneTools. Morpholinos were
injected unilaterally at the 2-cell stage (20 ng) and mRNA
for either lacZ (250 pg) or myc-GFP (125–250 pg) was
coinjected as a lineage tracer. Morpholino-injected embryos
were analysed either at neural plate (stage 14) or early tailbud
stages (stage 20–26).
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Embryo manipulations were performed in a plasticine
dish filled with 1 MBSH (Sive et al., 2000) supplemented
with 2 mM CaCl2 and 400 mg/l gentamycine (Sigma).
After removal of the vitelline membrane, embryos were
positioned in small grooves and fixed with plasticine.
Pieces of tissue were cut out using flamesharpened
tungsten needles. Grafts were held in position by a piece
of glass coverslip and were allowed to heal in for 1 to 2 h.
Embryos were then transferred to 0.1 MBS containing 25
mg/l gentamycine (Sigma), 400 mg/l penicillin (Sigma),
and 400 mg/l streptomycine sulphate (Sigma) and were
allowed to survive up to at least late neural fold stages
(stage 18–20) but usually until early tailbud stages (stage
20–26). Three types of manipulations were performed.
Extirpations involved the removal of tissues from embryos.
When parts of the neural plate were extirpated, care was
taken to leave the underlying mesoderm intact. For the
extirpation of axial or lateral endomesoderm, the overlying
ectoderm was left attached on one side and was folded
back over the wound after extirpation. When tissue grafts
were performed, donor and host embryos were either
distinguished by pigmentation and/or by using myc-GFP-
injected embryos as donors and uninjected embryos as
host. For ectodermal grafts (neural plate, placodal ecto-
derm, epidermal ectoderm, animal caps), a piece of
ectoderm was cut out from the host embryo and was
replaced by an ectodermal graft of similar size from the
donor. Care was taken to remove any mesodermal or neural
crest cells attached to the graft prior to transplantation. For
grafts of endomesoderm, a flap of belly ectoderm in the
host embryo was left attached on one side and folded back
to cover the graft after its transplantation into the ventral
endomesoderm. Grafts into the belly region of stage 13
embryos were always placed adjacent to the remnant of the
blastocoel and ended up in the anteroventral trunk region at
subsequent stages. Animal caps were taken from stage 9
embryos (see Sive et al., 2000). For explants, excised
pieces of tissue were transferred to microtiter plates
containing 0.5 MBS, 1% BSA, and 25 mg/l gentamycine
and cultured until sibling embryos had reached early
tailbud stages (stage 20–26).
Bead implantations
Recombinant mouse FGF8b (R&D Systems) was
applied using heparin acrylic beads (Sigma), whereas
recombinant human BMP4 (R&D Systems), recombinant
mouse noggin (R&D Systems), or noggin in combination
with FGF8b was applied using Affi-Gel Blue beads
(BioRad). Beads were prepared by washing 3  5V with
PBS containing 0.1% BSA followed by incubation in
protein solution (0.5–1 mg/ml diluted in PBS with 0.1%
BSA for each protein) for 2 h at room temperature or
overnight at 4-C. Control beads were treated identicallyexcept for incubation merely in PBS containing 0.1% BSA.
The inhibitor of FGF signalling SU5402 (Calbiochem) was
applied using AG 1-X2 resin beads (BioRad). Beads were
prepared by washing 3  5V with methanol, were then dried
at 37-C and incubated in 0.5 mM SU5402 (diluted in PBS
from a 300 mM stock solution in DMSO) overnight at 4-C.
Control beads, were treated identically except for incuba-
tion merely in PBS with DMSO (1:600). Beads were
implanted under the same culture conditions as embryo
manipulations. A small slit was made into the ectoderm
using flamesharpened tungsten needles and a bead was
gently pushed under the ectoderm using a blunt tungsten
needle. Wound edges were pressed down by a piece of
glass coverslip and were allowed to heal for 1 h. Embryos
were then allowed to survive up to at least late neural fold
stages (stage 18–20) but usually until early tailbud stages
(stage 20–26). Because beads tend to move after implanta-
tion, for all bead experiments, only those embryos were
included in the analysis, in which the bead was visibly
localised immediately subjacent to the ectoderm of the
targeted region (either lateral part of the pre-placodal region
or anteroventral belly ectoderm depending on the experi-
ment) after fixation.
Embryo incubations
For all incubation experiments, the vitelline membrane
of embryos was removed. For SU5402 incubations,
embryos were cultured in 0.5 MBS (blastula and
gastrula stages) or 0.1 MBS (from neural plate stages
on) and were transferred for defined developmental
periods to 60 AM SU5402 (diluted in 0.5 MBS or
0.1 MBS, respectively, from a 300 mM stock solution
in DMSO), in which they were incubated in the dark.
Controls were incubated in the dark in 0.5 MBS or
0.1 MBS, respectively, containing the same amount of
DMSO. At the end of the incubation period, embryos
were rinsed and cultured in 0.1 MBS until early tailbud
stages (stage 23–25). For BMP4 incubations, embryos
were reared in a solution of 100 ng/ml recombinant
human BMP4 in 0.5 MBS with 1% BSA from stage 13
until early tailbud stages (stage 20–23).
In situ hybridisation and immunohistochemistry
Embryos injected with myc-GFP were sorted under a
fluorescent stereomicroscope prior to fixation and were
then fixed overnight in 4% paraformaldhyde in 0.1 M
phosphate buffer (PB) and transferred to 70% ethanol.
LacZ-injected embryos were equally fixed overnight, then
stained with X-gal solution to reveal lacZ and transferred
to 70% ethanol. Wholemount in situ hybridisation was
carried out under high stringency conditions at 60-C as
previously described (Schlosser and Ahrens, 2004) using
digoxigenin-labelled antisense probes for Six1, Eya1, Sox3,
or FGF8. Probes were detected with an anti-digoxigenin
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BCIP as colour substrates. After in situ hybridisation, myc-
GFP was revealed immunohistochemically by rehydrating
the embryos, rinsing in PBS and incubating for 1–2 days
in anti-c-myc mouse antibody (9E10, Developmental
Studies Hybridoma Bank) diluted 1:1 in normal goat
serum and 5% DMSO. After 5 washes in PBS (1 h each),
embryos were incubated overnight at 4-C in FITC-
conjugated anti-mouse-IgG1 antibody (Southern Biotech-
nology Associates) diluted 1:100 in PBS and 5% DMSO.
After 5 h washes in PBS, embryos were stored in
fluorescent mounting medium (DAKO). In order to analyse
the distribution of gene expression domains or of
immunoreactivity for myc-GFP or Sox3 in more detail,
serial sections (30 Am vibratome sections or 10 Am
paraffine sections) were cut from selected embryos after
wholemount in situ hybridisation.
Immunohistochemistry for myc-GFP or Sox3 on sec-
tions was performed as previously described (Schlosser and
Ahrens, 2004). Sox3 was revealed using a polyclonal rabbit
anti-Sox3 antibody (Zhang et al., 2004; 1:1000) and an
FITC-conjugated anti-rabbit-IgG antibody (F0382, Sigma,
1:80). No unspecific binding of the secondary antibodies
was observed when the primary antibody was omitted in
control reactions (not shown).
In vitro transcription/translation and Western blot
In vitro transcription and translation were performed
using a TNT-coupled reticulocyte lysate kit (Promega)
according to the manufacturer’s instructions. 1 Ag of
pCS2+XFGF8 and 1 Ag of pCS2+XEya1a as a control
were added to each 25 Al reaction. The latter construct was
generated by cutting out the insert from pT-Adv-XEya1a
(David et al., 2001) with BamH1 and EcoRV and
subcloning it between the BamHI and StuI site of
pCS2+. 1 Ag of FGF8 MO or 1 Ag of control MO was
added to some reactions. The proteins synthesised were
analysed in Western blots using standard procedures.
Proteins were separated by SDS-PAGE on a 10% gel
and then transferred to a PVDF membrane. After
Coomassie-staining to reveal the position of protein length
markers, membranes were incubated overnight at 4-C with
a mixture of antibodies against FGF8 (goat anti-mouse-
FGF8b, AF-423-NA, R&D Systems; 0.2 Ag/Al) and against
Eya1 (guinea pig anti-Xenopus-Eya1, 1:10 000) in PBS
with 0.5% Triton. The latter antibody was generated
(Peptide Specialty Laboratories) by immunisation of
guinea pigs for the synthetically generated, HPLC-purified
peptide RLSGSGDSPSGTGLDNSHINS corresponding to
amino acids 12–32 of Xenopus Eya1. After washing in
PBS with 0.05% Tween, membranes were incubated in a
mixture of HRP-coupled secondary antibodies (rabbit anti-
goat, DAKO; 1:2000 and goat anti-guinea pig, Dianova;
1:10 000) for 1 h and visualised by chemiluminescence
(SuperSignal, Perbio).Results
Time course of placodal Six1 induction
To define the time window for placodal Six1 induction in
Xenopus, we compared timing, specification, and commit-
ment of Six1 expression with the presence of signals and
ectodermal competence for Six1 induction. Six1 starts to be
broadly expressed in dorsoanterior ectoderm at midgastru-
lation (stage 11.5) (Fig. 1A) and subsequently (stage 12)
becomes stronger (Fig. 1B). Comparison with Sox3
expression (Figs. 1I,J) reveals that Six1 expression during
these stages is confined to an anterior subdomain of the
Sox3-expressing dorsal ectoderm. At the end of gastrulation
(stage 12.5), when Sox3 expression has developed a sharp
boundary reflecting its restriction to the neural plate proper
(Figs. 1K,L), Six1 becomes specifically upregulated in the
crescent-shaped pre-placodal region but is downregulated in
the anterior neural plate (Figs. 1C,D). A similar new
crescent-shaped lateral domain of Sox3 expression also
appears at stage 12.5, which has been shown to overlap with
the Six1 crescent posteriorly but not anteriorly (Schlosser
and Ahrens, 2004).
To determine at what stage placodal Six1 expression is
specified, i.e., maintained in isolation (Slack, 1991),
ectoderm from the lateral part of the pre-placodal region
(henceforth LPR) was explanted at various stages, cultured
in vitro, and analysed after control embryos had reached
tailbud stages. The fraction of explants maintaining Six1
expression increases from 0% (0/12) at stage 13 to 27% (3/
11) at stage 14, 78% (15/19) at stages 15–16, and 100% (9/
9) at stage 20 (Figs. 2A,B). Thus, if we regard a tissue as
specified when more than 50% of the explants adopt the fate
in question in isolation, cells from the pre-placodal region
are specified to express Six1 at late neural plate stages
between stages 14 and 15/16.
To analyse at what stage placodal Six1 expression is
stably determined or committed, i.e., maintained even in a
foreign environment (Slack, 1991), the LPR was then
grafted at various stages into the belly of stages 13–15
host embryos and analysed after survival of hosts until
tailbud stages. Although different grafts ended up at slightly
different anteroposterior positions, the overwhelming major-
ity of grafts from all stages extended rostrally into regions
anterior to the fifth somite and Six1 expression within a graft
was not related to its anteroposterior position. None (0/11;
0%) of the grafts transplanted at stage 14, but 38% (16/42)
of the grafts transplanted at stages 15–17 and 100% (7/7) of
the grafts transplanted at stage 20 maintain Six1 expression
within the graft (Figs. 2C,D). Thus, if we consider a tissue
as committed when more than 50% of grafts adopt the fate
in question ectopically, cells from the pre-placodal region
are committed to express Six1 during neural fold stages
between stages 17 and 20.
Orthotopic grafts of the LPR from neural plate stage
donors (stage 13) into host embryos of different ages, which
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Fig. 2. Time course of placodal Six1 induction. (A,B) Specification of placodal Six1 expression. (A) Six1 expression persists in most LPR explants, explanted
at stage 16. (B) Percentage of LPR explants expressing Six1 after explantation at different stages and analysed after control embryos had reached early tailbud
stages (stage 20–26). (C,D) Commitment of placodal Six1 expression. (C) Six1 expression is maintained in LPR graft (arrowheads) after isochronic
transplantation into belly ectoderm at stage 15. (D) Percentage of grafts expressing Six1 after transplantation of LPR at different stages into stage 13–15 belly
ectoderm and survival of host until early tailbud stages (stage 20–26). Host ectoderm was not induced to express Six1 by grafts at any stage. (E–J) Ectodermal
competence and availability of signals for placodal Six1 induction. All host embryos were analysed after survival until early tailbud stages (stage 20–26). After
orthotopic transplantations (E,F), stage 13 donor LPR ectoderm expresses Six1 when grafted isochronically (E), but fails to do so when grafted into stage 16
hosts (F; insert shows control side of embryo). Heterotopic transplantations (G–I) reveal that belly ectoderm is competent to express Six1 when grafted into the
LPR of stage 13 hosts from stage 13 (G) up to at least stage 22 (I), but does not express Six1 when grafted into stage 16 hosts (H; insert shows control side of
embryo). Percentage of grafts expressing Six1 after transplantation of belly ectoderm at different stages into stage 13 LPR is indicated in (J). Light blue bars
indicate percentage of grafts exhibiting a disturbed pattern of Six1 expression.
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inducing signals are present only transiently. After trans-
plantation into hosts of the same stage, LPR grafts express
Six1 in a normal pattern (4/4; 100%) ruling out perturbations
by the grafting procedure itself (Fig. 2E). However, after
transplantating the LPR (Fig. 2F) or belly ectoderm (Fig. 2H)Fig. 1. Six1, FGF8, and Sox3 expression during early Xenopus development. E
(anterior to the left). (A–D) Weak Six1 expression (arrowheads) first appears in
becomes restricted to a crescent (arrowheads) around the anterior neural plate while
In addition to circumblastoporal expression, a new domain of FGF8 expression in
by stage 12 (F). By stage 12.5, expression of FGF8 is downregulated in dorsoa
(MHB) and three nested arcs (1–3) (G,H). (I –L) Sox3, for comparison, is broadly
restricted to the developing neural plate between stage 12 (J) and stage 12.5 (K). A
arrowhead) appears around the anterior neural plate (white arrowhead) (K,L). (M
posterior arcs (1,2) of FGF8 expression (M,O) are situated within the anterior neura
located outside of the neural plate. Arrowheads indicate Sox3 immunopositive nuc
summary of FGF8 expression relative to the expression of Sox3, Six1, and other m
2004). Blue line demarcates boundary of the lateral part of the pre-placodal region
areas from which ectoderm was taken for anterior neural plate (ANP), posterior ne
grafts and extirpations. The green line demarcates the region removed in unilaterinto the LPR of neural fold stage hosts (stage 16), Six1
expression is absent from the graft (3/3; 100% and 11/11;
100%, respectively) suggesting that by stage 16 signals are
insufficient for maintenance or induction of Six1.
In contrast, transplantation of belly ectoderm from
donors at various stages into the LPR of stage 13 hosts,mbryos are shown in dorsal (A–C, E–G, I–K) or lateral (D,H,L) views
dorsoanterior ectoderm at stage 11.5 (A), intensifies at stage 12 (B), and
being downregulated in the anterior neural plate at stage 12.5 (C,D). (E–H)
dorsoanterior ectoderm appears around stage 11.5 (E) and becomes stronger
nterior ectoderm except for the prospective midbrain–hindbrain boundary
expressed in dorsal and dorsoanterior ectoderm at stage 11.5 (I) but becomes
t stage 12.5, an additional crescent shaped domain of Sox3 expression (black
–O) Sagittal sections through embryo depicted in (G,H) reveal that the two
l plate marked by Sox3-immunostaining, whereas the anteriormost arc (3) is
lei immediately rostral to the second arc of FGF8 expression. (P) Schematic
arkers based on these data and on our previous report (Schlosser and Ahrens,
(LPR) used for grafts and extirpations. Yellow lines indicate boundaries of
ural plate (PNP), lateral neural plate (LNP), and anterior neural ridge (ANR)
al extirpations of the entire anterior neural plate (UNP).
Table 2
Placodal Six1 expression after extirpation of mesodermal and ectodermal
tissues
Extirpated tissue
(stage 13)
Gene Number of
experiments
Number of
individuals
Reduction
or loss of
expression
Axial mesoderm Six1 1 10 0 (0%)
Axial mesoderm +
overlying neural plate
Six1 2 12 3 (25%)a
Endomesoderm Six1 3 15 15 (100%)
Anterior neural
ridge (ANR)b
Six1 2 16 8 (50%)
Unilateral anterior
neural plate (UNP)b
Six1 3 18 18 (100%)
a In these cases, the extirpated region extended much further rostrally and
laterally than in the other 9 cases.
b See Fig. 1P for precise graft boundaries.
K. Ahrens, G. Schlosser / Developmental Biology 288 (2005) 40–5946which were analysed after survival until tailbud stages,
shows Six1 expression in 100% of the grafts from all
stages tested, viz. stage 13 (8/8), 15–16 (13/13) and 18–22
(10/10) indicating that ectodermal competence to respond
to Six1 inducing signals persists until at least early tailbud
stages (stage 22) (Figs. 2G,I,J). Moreover, the pattern of
Six1 expression is relatively normal in the majority of
grafts up to the last stages analysed, although the fraction
of grafts with perturbed pattern of Six1 expression (with
absence or major reduction of expression in at least one
type of placode) increases with time from 12.5% (1/8) at
stage 13 and 23% (3/13) at stage 15/16 to 40% (4/10) at
stages 18–22 (Fig. 2J).
Role of endomesoderm and neural plate in Six1 induction
To elucidate which tissues are involved in placodal Six1
induction, we performed several series of grafting and
extirpation experiments (for overview see Tables 1 and 2).
We first tested the Spemann organiser, because of its
proposed role in patterning the entire ectoderm (Sasai and
De Robertis, 1997; Chang and Hemmati-Brivanlou, 1998a;
Wilson and Edlund, 2001; De Robertis and Kuroda, 2004;
Niehrs, 2004). After grafting stage 11 organiser into the
belly of stage 13 hosts, ectopic Six1 is induced in adjacent
ectoderm (7/9; 78%). Six1 is often restricted to the anterior
graft border (4/9; 44%) and is always localised to the
anterior half of the embryo (Fig. 3A).
The capacity of the organiser to induce Six1 suggests
that signals for placodal Six1 induction during neural plate
and neural fold stages may come either from axialTable 1
Expression of various marker genes after mesoderm and ectoderm graftsa
Grafted tissue
(stage 13 unless
otherwise noted)
Place of implantation
in host (stage 13)
Gene
Organiser (stage 11) Belly Six1
Endomesoderm Belly Six1
Anterior neural plate (ANP)b Belly Sox3
FGF8
Eya1
Six1
+ BMP4 incubation Six1
+ SU5402 incubation Six1
Anterior neural plate (stage 12) Belly Six1
Anterior neural ridge (ANR)b Belly Six1
Lateral anterior neural plate (LNP)b Belly Six1
Posterior neural plate (PNP)b Belly Six1
Lateral part of pre-placodal region (LPR)b Belly FGF8
Belly Unilateral anterior
neural plate (UNP)b
Six1
a Grafting experiments analysing specification, commitment, competence, and p
these experiments, see Fig. 2.
b See Fig. 1P for graft boundaries.
c Unequivocal expression within graft in seven cases; the remaining six cases pr
be ascertained.
d Expression in these cases extended beyond graft boundaries into adjacent hosmesoderm directly derived from the organiser or from
secondary signalling centers in more lateral mesoderm or
neural plate, which are induced by the organiser (Wilson
and Edlund, 2001; De Robertis and Kuroda, 2004; Niehrs,
2004). We first tested the cranial dorsolateral endomeso-
derm subjacent to the pre-placodal region. Grafting stage
13 dorsolateral endomesoderm into the belly of a stage 13
host does not induce Six1 in overlying belly ectoderm (0/9;
0%) (Fig. 3C), although placodal Six1 expression is
strongly reduced after its extirpation (15/15; 100%) (Fig.
3D). This indicates that dorsolateral endomesoderm is
necessary for placodal Six1 induction, but not sufficient for
its ectopic induction in belly ectoderm. In contrast,
extirpation of axial mesoderm either alone (not shown;Number of
experiments
Number of
individuals
Ectopic
expression in
host ectoderm
next to graft
Expression
within the graft
2 9 7 (78%) 0 (0%)
2 9 0 (0%) 0 (0%)
2 9 0 (0%) 9 (100%)
1 6 0 (0%) 6 (100%)
2 17 9 (53%) 0 (0%)
6 38 28 (74%) 0 (0%)
1 9 1 (11%) 0 (0%)
1 9 2 (22%) 0 (0%)
1 9 2 (22%) 0 (0%)
2 13 13 (100%) 13 (100%)c
1 7 0 (0%) 0 (0%)
1 10 0 (0%) 0 (0%)
1 10 0 (0%) 2 (20%)
3 12 3 (25%)d 11 (92%)
resence of signals for Six1 induction are not included here; for summary of
obably also had expression within graft but precise border of graft could not
t ectoderm.
Fig. 3. Role of organiser and endomesoderm in placodal Six1 induction. All embryos were analysed at early tailbud stages (stage 20–26). (A) Grafting a
stage 11 organiser (dorsal blastopore lip) into stage 13 belly ectoderm induces Six1 expression (arrowhead) in host ectoderm next to anterior edge of graft.
(B) After extirpation of axial mesoderm together with the overlying central neural plate at stage 13 bulging endoderm (asterisk) prevents regeneration of
mesoderm and closure of the neural tube without resulting in any major deficits of placodal Six1 expression. (C) Grafting stage 13 cranial dorsolateral
endomesoderm (green GFP label) into stage 13 belly ectoderm does not induce Six1 but placodal Six1 expression is lost in donors (D). Control side (CS)
shown in insert for comparison.
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does not perturb placodal Six1 expression (19/22; 86%)
(Fig. 3B) except for a slight reduction in cases where the
extirpated region extended far rostrally and laterally (3/22;
14%; not shown). While we cannot rule out that there may
have been partial regeneration of axial mesoderm in some
cases, in the majority of those cases where axial mesoderm
was extirpated together with the central neural plate,
protruding endodermal cells effectively prevented regener-
ation of axial mesoderm as well as closure of the neural
tube (Fig. 3B). Thus, taken together, our results suggest
that axial mesoderm is dispensable for placodal Six1
induction.
Another candidate source for Six1 inducing signals is the
neural plate itself. To test this, we transplanted stage 13
anterior neural plates (region ANP of Fig. 1P) into the belly
ectoderm of stage 13 hosts. Anterior neural plate grafts are
committed to neural fate as judged by their strong Sox3
expression (9/9; 100%) (Fig. 4A) and they induce strong
expression of Six1 (28/38; 74%) (Figs. 4C–G) and some-
what weaker expression of Eya1 (9/17; 53%) (Fig. 4B) in
the ectoderm. Ectopic Six1 expression is confined to host
ectoderm (Figs. 4D–F). In contrast to the animal cap grafts
reported below, Six1 induction typically occurs in a ring-
shaped domain around the graft (Fig. 4C) and expression at
the posterior border of the graft is often located at midtrunk
levels posterior to the fifth somite.
These experiments demonstrate that the anterior neural
plate is a potent inducer of placodal Six expression. To
further map the spatial distribution of Six1 inductive
activity within the neural plate, we grafted other parts of
stage 13 neural plates into the belly of stage 13 hosts.
Anterior neural ridge grafts (ANR in Fig. 1P) likewiseinduce strong Six1 expression in the surrounding ectoderm
(13/13; 100%), but additionally express Six1 within the
graft (Fig. 4H) suggesting that they include part of the pre-
placodal ectoderm from the outer neural folds (Schlosser
and Ahrens, 2004). In contrast, ectoderm grafts from the
cranial lateral neural folds (lateralmost anterior neural plate
and adjacent neural crest; LNP in Fig. 1P) neither express
Six1 nor induce Six1 in the adjacent ectoderm (0/7; 0%;
data not shown). The posterior neural plate (PNP in Fig.
1P) is also unable to induce Six1 (0/10; 100%) (Fig. 4I)
indicating that inductive activity is confined to the anterior
neural plate. The anterior neural plate does not appear to
be committed to express signals for Six1 induction before
the end of gastrulation, because grafts of prospective
anterior neural plate from stage 12 donors into the belly
of stage 13 hosts still mostly fail to induce Six1 (Fig. 4J)
except for a few Six1 positive cells in some embryos
(2/9; 22%).
To test whether the anterior neural plate is required for
placodal Six1 induction, we next extirpated either the ANR
bilaterally (see Fig. 1P) or the entire anterior neural plate
unilaterally (region UNP in Fig. 1P) from stage 13
embryos, leaving the underlying mesoderm intact. While
ANR extirpation frequently interferes with anterior but not
posterior domains of placodal Six1 expression (8/16; 50%)
(Fig. 4K), unilateral extirpation of the entire anterior neural
plate always results in strong reduction of placodal Six1 at
all anteroposterior levels (18/18; 100%) (Fig. 4L). When
stage 13 belly ectoderm was grafted in place of the
extirpated anterior neural plate, Six1 expression is induced
throughout the graft (11/12; 92%) and sometimes extends
into host ectoderm ventral to the graft (Fig. 4M). These
experiments indicate that anterior neural plate is not only
Fig. 4. Role of neural plate in placodal Six1 induction. Embryos shown in lateral views (anterior to the left). Transplantations involved hosts and donors at early
neural plate stage (stage 13) unless otherwise noted (see Fig. 1P for precise location of ectoderm grafted). All embryos were analysed at early tailbud stages
(stage 20–26). (A–G) Grafts of anterior neural plate (ANP) in belly ectoderm strongly express Sox3 (A) and induce Eya1 (B, enlarged in insert) and Six1 (C)
in surrounding ectoderm. (D–F) Cross-section of a neural plate graft (green GFP label) shows confinement of Six1 to host ectoderm. (G) Anterior neural plate
grafts induce Six1 in surrounding belly ectoderm in 74% (28/38) when left untreated, but in only 22% (2/9) or 11% (1/9) when treated with the FGF inhibitor
SU5402 or with BMP4 after transplantation, respectively. (H) Anterior neural ridge (ANR) grafts (enlarged in insert) in belly ectoderm express Six1 at their
border (arrowhead) and induce it in adjacent ectoderm (arrow). Grafts of (I) posterior neural plate (PNP) or (J) stage 12 anterior neural plate do not induce Six1
in belly ectoderm. (K) ANR extirpation leads to reduction of anterior domains of placodal Six1 expression. (L) Unilateral extirpation of anterior neural plate
(UNP) results in loss of placodal Six1 expression (white arrowheads; compare to Six1 expression on control side as indicated by black arrowheads) except for
weak expression domain (arrow) next to remnants of neural folds (NF). (M) Six1 is expressed broadly (arrowhead) in belly ectoderm grafted unilaterally into
anterior neural plate, sometimes extending into host ectoderm (arrow).
K. Ahrens, G. Schlosser / Developmental Biology 288 (2005) 40–5948able to induce Six1 ectopically in belly ectoderm, but that
juxtaposition of anterior neural plate and nonneural
ectoderm is necessary for placodal Six1 induction and thatinducing signals from the neural plate may spread (directly
or indirectly) relatively far within the plane of the
ectoderm.
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To elucidate the inductive signals involved in placodal
Six1 induction, we first analysed the role of BMP
inhibition (for overview see Table 3), which has previously
been implicated in placodal Six1 induction (Glavic et al.,
2004; Brugmann et al., 2004). Incubating embryos in a
BMP4 solution from stage 13 to early tailbud stages
(stages 20–23) leads to no visible reduction of placodal
Six1 expression (0/20, 0%). However, when a stage 13
neural plate is grafted into the belly of a stage 13 host
followed by immediate BMP4 treatment until stage 20,
grafts are able to induce weak Six1 expression in the
adjacent ectoderm only in exceptional cases (1/9; 11%) in
contrast to neural plate grafts in untreated embryos (28/38;
74%; see above) (Fig. 4G).
The absence of any obvious effects on placodal Six1
expression in these types of incubations raised the possi-
bility of poor tissue penetration of BMP4. We, thus, raised
effective BMP levels in the LPR during the period of
placodal Six1 induction in a more specific and localised
fashion by implanting either animal caps from BMP4-
injected embryos (Fig. 5A) or BMP4-soaked beads (Fig.
5B) into the LPR at stage 13. Both sources of BMP4
strongly suppress placodal Six1 expression (animal caps: 7/
7; 100%; beads: 13/13; 100%), while control animal caps
from uninjected embryos or control beads do usually not
affect placodal Six1 expression (animal caps: 0/7; 0%;
beads: 1/17: 6%). This observation suggests that BMPTable 3
Expression of various marker genes after animal cap grafts or bead implantations
Grafted animal
caps (AC) or beads
Place of
implantation
in host
(stage 13)
Gene Number of
experiments
BMP4-AC LPRa Six1 1
BMP4 bead LPRa Six1 2
SU5402 bead LPRa Six1 1
Uninjected control AC LPRa Six1 1
Sox3 1
Control bead LPRa Six1 4
noggin-AC Belly Six1 4
Sox3 3
FGF8 1
Noggin bead Belly Six1 4
dnBMPR-AC Belly Six1 6
Sox3 2
FGF8-AC Belly Six1 3
FGF8 bead Belly Six1 3
noggin + FGF8-AC Belly Six1 2
Sox3 1
noggin + FGF8 bead Belly Six1 3
Uninjected control AC Belly Six1 2
Sox3 1
Control beads Belly Six1 2
a LPR = lateral placodal region; see Fig. 1P for precise graft boundary.
b Residual placodal expression domains of Six1 or Sox3 in host ectoderm exten
c In a few cases, a very weak expansion of the placodal Sox3 domain of the hoinhibitors must sequester BMPs after completion of
gastrulation to permit placodal Six1 induction, because
BMP4 is strongly expressed in the pre-placodal region at
neural plate and fold stages (Fainsod et al., 1994; Hemmati-
Brivanlou and Thomsen, 1995; Schmidt et al., 1995).
Transplantations of animal cap ectoderm into the LPR of
stage 13 hosts result in strong induction of Sox3 (7/7; 100%)
(Fig. 5C) but not of Six1 expression (except 1/7; 14%) (Fig.
5D) within the graft indicating that the resulting effective
BMP levels in the prospective placodal region are low
enough to completely neuralise ectoderm that is still
neurally competent.
To determine whether BMP inhibition is sufficient to
induce Six1 in competent ectoderm, we next created an
ectopic source of BMP inhibitors by grafting animal caps
from embryos injected with the diffusible BMP inhibitor
noggin into stage 13 belly ectoderm. This results in
pronounced broadening and posterior expansion of the
placodal Six1 domain of the host towards the graft (23/29;
79%), but never leads to ectopic Six1 expression (Fig. 5H).
Six1 expression also never extends around the posterior
border of the grafts but typically fades out at approximately
the level of the fifth somite.
However, unlike the adjacent belly ectoderm (which has
lost neural competence), noggin-injected animal caps are
neuralised as judged by their expression of Sox3 (17/17;
100%) (Fig. 5E). This raises the possibility that noggin may
induce Six1 indirectly by promoting expression of other
signalling molecules within the graft. To test this, we graftedNumber of
individuals
Ectopic
expression in
host ectoderm
next to graft
Reduction
or loss of
expression
in host
Expression
within the
graft
7 n/a 7 (100%) 0 (0%)
13 n/a 13 (100%) n/a
9 n/a 8 (89%) n/a
7 n/a 0 (0%)b 1 (14%)
7 n/a 0 (0%)b 7 (100%)
17 n/a 1 (6%) n/a
29 23 (79%) n/a 0 (0%)
17 0 (0%)c n/a 17 (100%)
13 0 (0%) n/a 7 (54%)
14 0 (0%) n/a n/a
34 8 (24%) n/a 0 (0%)
12 0 (0%)c n/a 12 (100%)
29 10 (35%) n/a 0 (0%)
9 0 (0%) n/a n/a
19 17 (89%) n/a 0 (0%)
5 0 (0%)c n/a 5 (100%)
8 6 (75%) n/a n/a
19 5 (26%) n/a 0 (0%)
4 0 (0%) n/a 4 (100%)
4 0 (0%) n/a n/a
d until border of animal cap grafts.
st towards the graft was observed.
Fig. 5. Role of BMP inhibitors and FGF8 in placodal Six1 induction. Embryos shown in lateral views (anterior to the left). Transplantations involved hosts at
early neural plate stage (stage 13) and were analysed at late neural fold or early tailbud stages (stage 18–26). (A,B) Implanting animal caps (pigmented) from
BMP4-injected embryos (A) or beads (red asterisk; the bead itself is light blue) soaked with BMP4 (B) repress placodal Six1 expression (arrowheads) around
grafts or beads, respectively. Insert in panel B shows control side (CS). (C,D) Animal caps from uninjected embryos grafted into the LPR strongly express Sox3
(C) but not Six1 despite normal Six1 expression in host ectoderm (D). (E–M) Animal caps (pigmented, green GFP label, arrows) from embryos injected with
various constructs (E–J) or protein-soaked beads (K–M) were grafted into belly ectoderm. (E) noggin-injected grafts strongly express Sox3. (F) dnBMPR-
injected grafts also express Sox3, but expression tends to be somewhat weaker and more patchy. (G) dnBMPR-injected grafts do not or only weakly affect
placodal Six1 expression of host, whereas (H) noggin-injected grafts significantly broaden (arrowhead) placodal Six1 expression of host towards anterior graft
border. (I) FGF8-injected grafts only weakly broaden (arrowhead) placodal Six1 expression in few cases. (J) noggin and FGF8 coinjected grafts broaden
placodal Six1 expression and strongly induce Six1 (arrowhead) at anterior graft border. Beads (red asterisks) soaked with noggin (K) or FGF8 (L) alone do not,
but beads soaked with noggin and FGF8 (M) do induce ectopic Six1 expression in ectoderm (beads enlarged in insert; Affi-Gel Blue beads used in panels K and
M are light blue, while heparin acrylic beads used in panel L are colourless). (N–P) Anterior neural plate from stage 13 donors retains FGF8 expression after
transplantation into belly ectoderm. Transverse sections (O,P) through embryo shown in panel N clearly show FGF8 expression (O) confined to GFP-labeled
graft (P). (Q) In contrast, FGF8 expression is typically not maintained in LPR from stage 13 donors after transplanting into belly ectoderm.
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Table 4
Effects of FGF8 morpholino injections
Gene Number of
experiments
Number of
individuals
Reduction or
loss of expression in
placodal domain
Reduction of
neural plate
expression
Six1 8 68 45 (66%) n/a
Eya1 2 14 9 (64%) n/a
Sox3 5 60 33 (55%) 0 (0%)
FGF8 3 14 8 (57%) 0 (0%)
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receptor (dnBMPR) (Graff et al., 1994), expected to block
BMP signalling within the graft without diffusing into host
tissues. Although dnBMPR-injected animal caps are also
neuralised judged by Sox3 expression (12/12; 100%) (Fig.
5F), they have either no effect on placodal Six1 expression
of the host (26/34; 76%) or only weakly broaden it in a few
cases (8/34; 24%) (Fig. 5G). This is similar to the effect
obtained after transplantation of uninjected animal caps
(data not shown), which also show weak Sox3 expression
(4/4; 100%), but only rarely lead to some broadening of
placodal Six1 expression (5/19; 26%). Taken together, our
results suggest that diffusion of BMP inhibitors from the
grafts contributes to the expansion of placodal Six1
expression. However, noggin beads alone cannot elicit
ectopic Six1 expression in anterior belly ectoderm (0/14;
0%) (Fig. 5K), indicating that BMP inhibition alone is
insufficient for Six1 induction and is only effective in
conjunction with additional factors emanating from neural-
ised animal caps.
FGF8 is necessary for placodal Six1 induction and is
sufficient to induce Six1 in anterior ectoderm when BMP is
inhibited
FGF8 is a promising candidate for such a neural plate-
derived signal, because its spatiotemporal expression in the
anterior neural plate (Christen and Slack, 1997) correlates
closely with the onset of placodal Six1 expression and with
the distribution of Six1 inducing activity in the neural plate
(Fig. 1). Similar to Six1, FGF8 expression in dorsoanterior
ectoderm first appears at stage 11.5 and intensifies at stage
12 (Figs. 1E,F). Subsequently, FGF8 is maintained in the
prospective midbrain–hindbrain boundary and in three
nested arcs (Figs. 1G,H). Immunostaining with Sox3 anti-
bodies reveals that the outermost of these arcs lies in the
nonneural ectoderm surrounding the neural plate, while the
two inner arcs are located within the anteriormost neural
plate (Figs. 1M–P).
To investigate the Six1-inducing capacity of FGF8 (for
overview see Table 3), we first grafted animal caps from
embryos injected with FGF8 alone (with weak Sox3
expression in 5/7 cases; 71%) into stage 13 belly ectoderm.
Such grafts only slightly expand the placodal Six1 domain
of the host in few cases (10/29; 35%) (Fig. 5I). In contrast,
animal caps of embryos coinjected with noggin and FGF8
(with Sox3 expression in 5/5 cases; 100%) not only lead to
drastic expansion of the placodal Six1 domain of the host
(17/19; 89%), but also result in strong ectopic induction of
Six1 around the anterior graft border (14/19; 74%) (Fig. 5J).
Expression was, however, again absent from the posterior
graft border, approximately from the level of the fifth
somite on. Ectopic Six1 expression is also induced in
anterior belly ectoderm (stage 13) after implantation of
beads soaked in FGF8 and noggin (6/8; 75%) (Fig. 5M) but
not of control beads (0/4; 0%) or beads soaked in eithernoggin (0/14; 0%) (Fig. 5K) or FGF8 (0/9; 0%) (Fig. 5L)
alone. These results indicate that Six1 induction can indeed
be attributed to FGF8 and noggin and not to other
signalling molecules emanating from FGF8 and noggin
coinjected caps.
We further show that the capacity of stage 13 anterior
neural plate grafts (Figs. 4C–G) to induce ectopic Six1
expression correlates with their maintenance of FGF8
expression (6/6; 100%) (Figs. 5N–P), whereas LPR grafts,
which cannot induce Six1 (Figs. 2C,D), do not maintain
FGF8 expression (except for weak expression in 2/10 cases;
20%) (Fig. 5Q) after transplantation to belly ectoderm.
Noggin-injected animal caps grafted to stage 13 belly
ectoderm also express FGF8 weakly (7/13; 54%) (data
not shown) which may contribute to their capacity to
upregulate placodal Six1 expression in anterior belly
ectoderm in contrast to noggin coated beads.
To analyse whether FGF signalling is necessary for
placodal Six1 induction (for overview see Tables 3 and 4),
we blocked the FGF pathway by incubating embryos in the
FGF inhibitor SU5402 (Mohammadi et al., 1997). Embryos
treated from stage 8 until 12 show gastrulation defects and,
thus, were not further analysed (not shown). Strong
reduction of placodal Six1 expression is observed in all
embryos (24/24; 100%) treated from stages 12–13 until
stage 20 but only in few embryos (3/18; 16.7%) treated from
stages 18 until 25 (Figs. 6A–C). Furthermore, when stage
13 embryos that had received a stage 13 neural plate graft
into the belly are immediately incubated in SU5402 until
stage 20, only a small fraction of grafts can induce weak
Six1 expression in the adjacent ectoderm (2/9; 22%) in
contrast to neural plate grafts in untreated embryos (28/38;
74%; see above) (Fig. 4G).
Similar to what we found after BMP incubations (see
above), the maintenance of low level placodal Six1
expression in such incubation experiments may possibly
reflect poor tissue penetration of the SU5402 solution. In
order to address this, we implanted SU5402-soaked beads
directly under the pre-placodal ectoderm at stage 13.
Whereas control beads had no effect (16/17; 94%), Six1
expression is completely lost from the ectoderm immedi-
ately overlying SU5402-soaked beads regardless of where
in the placodal region they are located (8/9; 89%) (Figs.
6D,E). Thus, FGF signalling seems to be required for Six1
expression in the entire pre-placodal region.
Fig. 6. FGF signalling is necessary for placodal Six1 induction. Embryos shown in lateral (A,B,D,E; anterior to the left), dorsal (G– I; anterior to the top), or
frontal views (J,K; midline in panel K indicated by dotted line). Embryos were analysed at early tailbud stages (stages 20–26: A–E, K) or neural plate stages
(stage 14: G–J). (A) Placodal Six1 expression is reduced in embryos treated with SU5402 (stages 12/13–20) compared to controls (B). (C) Percentage of
embryos with reduced Six1 expression after SU5402 treatment during different periods. (D,E) SU5402-soaked beads inhibit Six1 expression (arrowheads) after
implantation at stage 13 into the region of the prospective ear placode (D) or of prospective trigeminal, lateral line, and epibranchial placodes (E). (F) Western
blot demonstrating that the FGF8 MO but not an unspecific control MO specifically blocks in vitro translation of FGF8 but not of Eya1. (G–K) Embryos
unilaterally injected with FGF8 MO (to the left on each panel) show strong reductions (arrowheads) of placodal Six1 (G,J,K), Sox3 (H), and FGF8 (I)
expression, while neural plate domains of Sox3 or FGF8 expression are not reduced (asterisks). Both posterior (G,K) and anterior (J,K) subdomains of placodal
Six1 expression are reduced in embryos analysed at neural plate (G,J) or tailbud stages (K; lower and upper arrowheads indicate olfactory and otic placode,
respectively). The injected side was marked by coinjection of either GFP (G–I; not shown) or lacZ (J,K; light blue staining).
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antisense oligonucleotide (MO) to specifically block FGF8
translation. Western blots reveal that this FGF8 MO indeed
specifically blocks the synthesis of FGF8 but not of another
protein Eya1 serving as a control during in vitro tran-scription and translation reactions of the corresponding
expression vectors, while an unspecific control MO does not
interfere with synthesis of either protein (Fig. 6F). Injections
of FGF8 MO lead to severe reduction of the placodal
expression domains of Six1 (45/68; 66%) (Figs. 6G,J,K),
K. Ahrens, G. Schlosser / Developmental Biology 288 (2005) 40–59 53Eya1 (9/14; 64%; not shown), Sox3 (33/60; 55%) (Fig. 6H),
and FGF8 (8/14; 57%) (Fig. 6I) without inhibiting neural
plate domains of Sox3 (0/60; 0%) (Fig. 6H) or FGF8 (0/14;
0%) (Fig. 6I). Injections of control morpholinos have no
effects (not shown). This suggests that specifically the
placodal domains of all genes analysed (including FGF8
itself) but not their neural domains depend on a FGF8
signal. We attempted to rescue the effects of FGF8 MO by
coinjecting flag-tagged FGF8 mRNA or DNA but coinjec-
tion of even low concentrations of FGF8 broadens the
neural plate at the expense of Six1 similar to injection of
FGF8 alone (not shown). These neuralising effects of FGF8
preclude an independent analysis of its potential to rescue
Six1 induction. Following FGF8 MO injection, posterior
placodal Six1 expression domains (including the otic
placode) are often more strongly reduced (Figs. 6G–I)
probably due to anterior compensation by FGF8 from the
uninjected side. However, in many specimens, defects are
not confined to posterior regions, but are also observed in
more anterior (e.g. olfactory) placodal expression domains
(Figs. 6J,K). This indicates that FGF8 is essential for
inducing Six1 and other placodal markers in the entire
panplacodal primordium.Discussion
Neural plate-derived signals induce Six1 in nonneural
ectoderm receiving additional signals from dorsolateral
endomesoderm
Our experiments show that the anterior neural plate is not
only necessary for placodal Six1 induction but is sufficient
to induce Six1 and Eya1 in ventral ectoderm (see also Woda
et al., 2003; Glavic et al., 2004). Although induction of
Eya1 in our neural plate grafts tended to be weaker and was
observed in fewer cases, this probably merely reflects the
lower sensitivity of the Eya1 probe compared to the Six1
probe during in situ hybridisation inferred from its generally
slower and weaker development of staining. Other genes
with widespread placodal expression like Xiro1 (Glavic et
al., 2004), can also be induced by anterior neural plate.
Taken together, this suggests that the anterior neural plate is
an essential source of signals for generic placode induction
in Xenopus. We find, however, that the capacity to induce
Six1 is unevenly distributed in the anterior neural plate
probably reflecting the uneven distribution of candidate
signalling molecules such as FGF8 as will be discussed in
more detail below.
In contrast, the cranial dorsolateral endomesoderm,
which includes mesodermal precursors for the pharyngeal
arches and heart (Keller, 1976), is required for placodal Six1
induction, but cannot induce Six1 in ventral ectoderm
suggesting that it functions in creating a permissive
environment for placodal Six1 induction possibly by
contributing to BMP inhibition as discussed below. Whileour extirpation experiments demonstrate that axial meso-
derm is dispensable for placodal Six1 induction, it never-
theless may constitute a more permissive environment for
placodal Six1 induction than ventral mesoderm. This is
suggested by our observation that Six1 is induced broadly
within the graft after transplantation of belly ectoderm into
the neural plate, whereas it is induced only in a circum-
scribed ring of belly ectoderm after transplantation of neural
plate to belly.
A recent study in chick embryos has also revealed a role
for both neural plate and endomesoderm in placode
induction (Litsiou et al., 2005). However, in contrast to
our findings, future heart mesoderm of the chick was found
to promote ectopic induction of various panplacodal
markers including Six1 in extraembryonic ectoderm (Litsiou
et al., 2005). Moreover, neural plate grafts in chick induce
Six1 and Eya2 in the adjacent ectoderm in only a small
fraction of cases, while they induce some additional
placodal markers (Dach1) but not others (Six4) (Litsiou et
al., 2005). Whether these apparent differences between frog
and chick really reflect fundamental interspecific differences
in the inductive capacity of endomesoderm and neural plate
is currently unclear. Alternatively, the different results may
relate to the different types of responding ectoderm used in
the grafting experiments in Xenopus and chick embryos,
respectively, which are nonequivalent in competence (e.g.,
neural competence is still demonstrably present in chick
extraembryonic ectoderm but not in Xenopus belly ecto-
derm; Kintner and Dodd, 1991; Servetnick and Grainger,
1991; Litsiou et al., 2005). Additional experiments are
needed to clarify this issue.
Unfortunately, the molecular basis of competence for
placode induction is still unknown. However, we show here
that, at ectopic neural plate boundaries, Six1 induction is
always confined to host tissues indicating that ectodermal
competence for Six1 induction is strictly limited to non-
neural ectoderm. The widespread and longlasting distribu-
tion of competence for Six1 induction in the nonneural
ectoderm reflects the distribution of Dlx3 (Schlosser and
Ahrens, 2004), which is necessary for ectodermal Six1
induction (Woda et al., 2003; see also McLarren et al.,
2003). This suggests that Dlx3 may play a central role in
mediating placodal competence.
Interactions between neural plate and the epidermis are
also required for the induction of the neural crest, another
neural plate border fate (reviewed in Mayor and Aybar,
2001; Knecht and Bronner-Fraser, 2002). However, several
of our observations indicate that generic placode induction
relies on inductive processes distinct from neural crest
induction. First, specification and loss of ectodermal
competence occur substantially later for placodal Six1
induction (after neural plate stages) than for induction of
neural plate and neural crest. The latter are specified at the
end of gastrulation in Xenopus (Mayor et al., 1995; Mancilla
and Mayor, 1996), when competence for neural and neural
crest induction declines in nonneural ectoderm (Kintner and
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Mayor, 1996). Second, Six1 is only induced on the
epidermal side of ectopic neural plate borders, whereas
neural crest markers are induced on both sides of the border
(Moury and Jacobson, 1990; Selleck and Bronner-Fraser,
1995; Mancilla and Mayor, 1996). In Xenopus, induction of
neural crest markers is even confined to the neural plate
when neural plates are grafted into epidermis of neural plate
stage (stage 13) hosts (Ahrens and Schlosser, unpublished
observations), reflecting the loss of competence for neural
crest formation in nonneural ectoderm at the end of
gastrulation (Mancilla and Mayor, 1996). And third, tissues
and signals involved in generic placode induction differ
from those implicated in neural crest induction. While
placodal Six1 induction relies on signals from the neural
plate and from dorsolateral endomesoderm (including FGF8
and BMP inhibitors), neural crest is induced by epidermis-
or paraxial mesoderm-derived signals such as Wnts or FGFs
(Mayor et al., 1997; Bang et al., 1997, 1999; La Bonne and
Bronner-Fraser, 1998; Bonstein et al., 1998; Marchant et al.,
1998; Chang and Hemmati-Brivanlou, 1998b; Sasai et al.,
2001; Garcia-Castro et al., 2002; Villanueva et al., 2002;
Monsoro-Burq et al., 2003; Bastidas et al., 2004).
Placodal Six1 induction requires BMP inhibition but does
not depend on a BMP gradient
In accordance with previous observations that BMP
inhibitors induce Six1 in isolated animal caps (Brugmann et
al., 2004), we show here that animal caps from noggin-
injected embryos but not from dnBMPR-injected embryos
strongly broaden placodal Six1 expression. Because both
noggin and dnBMPR are expected to block BMP signalling
within the graft while only noggin is diffusible, this suggests
that induction of Six1 depends on diffusion of BMP
inhibitors from the grafts rather than on other signals
produced by the grafted tissue in response to reduced BMP
signalling within the graft. Whether BMP inhibition in the
responding ectoderm affects Six1 expression directly or
indirectly remains to be shown in future studies.
However, our experiments reveal that BMP inhibitors are
only effective in conjunction with additional factors
emanating from neuralised animal caps (including possibly
FGF8, which we have shown to be present in neuralised
animal caps) because noggin beads cannot induce Six1
ectopically. Since noggin-injected grafts appear to be more
thoroughly neuralised than dnBMPR-injected grafts judged
by their generally more intense and less patchy Sox3
expression, higher levels of such additional factors may
contribute to the higher inductive capacity of noggin-
injected grafts. That BMP inhibitors must synergise with
additional signals to promote generic placode induction is
also supported by observations that other placodal markers
including Six4, Eya2, and Xiro1 are only expanded but not
ectopically expressed after blocking BMP signalling (Glavic
et al., 2004; Litsiou et al., 2005).We further demonstrate, that BMP4 inhibits Six1
induction around neural plate grafts and that raising
BMP4 levels in the placodal region suppresses placodal
Six1 expression, suggesting that low effective BMP levels
are required for placodal Six1 induction and maintenance.
However, during neural plate and neural fold stages, BMP4
is expressed at high levels precisely in the pre-placodal
ectoderm (Fainsod et al., 1994; Hemmati-Brivanlou and
Thomsen, 1995; Schmidt et al., 1995) suggesting that BMP
inhibitors must sequester BMPs during these stages in order
to permit placodal Six1 induction. Because axial mesoderm
is dispensable for placodal Six1 induction, these BMP
inhibitors most likely come from the dorsolateral endome-
soderm and/or the neural plate, which are here shown to be
required for placodal Six1 induction. The dorsolateral
endomesoderm expresses cerberus (Bouwmeester et al.,
1996), known to act as a multifunctional antagonist of BMP,
Wnt, and nodal signalling (Piccolo et al., 1999; Silva et al.,
2003), whereas the neural plate weakly expresses noggin
(Knecht and Harland, 1997). It is tempting to speculate that
the ability of the anterior neural plate to strongly induce
Six1 in belly ectoderm in contrast to FGF8-injected animal
caps may be attributable to neural plate-derived BMP
inhibitors but this remains to be tested. Additional experi-
ments are clearly needed to elucidate the relative importance
of the various candidate sources of BMP inhibitors for
generic placode induction.
The findings discussed so far indicate that high levels of
BMP are incompatible with placodal Six1 induction but do
not preclude a role of intermediary BMP-concentrations for
placodal Six1 induction. Our following observations, how-
ever, argue against this possibility. The induction of Sox3
but not of Six1 in stage 9 animal caps ectoderm grafted to
the placodal region at neural plate stages reveals that the
effective BMP levels in the pre-placodal region during these
stages are low enough to permit neural induction in neurally
competent ectoderm (see also Holtfreter, 1933; Albers,
1987; Bastidas et al., 2004). Furthermore, stage 13 belly
ectoderm is induced to express Six1 when transplanted into
the neural plate, where it is subjected to strong BMP
inhibition by axial mesoderm (Smith and Harland, 1992;
Lamb et al., 1993; Sasai et al., 1995). Together, this strongly
argues against the gradient model proposing that induction
of generic placodal versus neural cell fates occurs at
intermediate and low BMP levels, respectively (Sasai and
De Robertis, 1997; Neave et al., 1997; Nguyen et al., 1998;
Glavic et al., 2004; Brugmann et al., 2004). Instead, it
suggests that differences in ectodermal competence deter-
mine whether neural or placodal markers are induced in
regions of low effective BMP levels.
Placodal Six1 induction requires FGF8 signals, probably
derived from the anterior neural plate
Our animal cap and bead grafts establish that FGF8 in
conjunction with BMP inhibitors but not FGF8 alone is able
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beads coated with FGF8 and noggin also induce Six1
ectopically, dependance on secondary signals, which may be
activated in FGF8 and noggin coinjected animal caps, can
be ruled out. However, our experiments do not allow us to
infer whether FGF8 and noggin induce Six1 directly or
indirectly in the responding tissue.
Placodal expression of Six1 and other placodal markers is
lost or drastically reduced after knockdown of FGF8
indicating that FGF8 is in fact essential for generic placode
induction in Xenopus. Our SU5402 incubations and bead
implants reveal that FGF signalling is specifically required
during neural plate and neural fold stages, when commit-
ment for placodal Six1 expression occurs. We further show
that FGF inhibition reduces Six1 and other panplacodal
markers not only in the otic placode but in the entire
panplacodal primordium. Expression domains of Pax6,
Pax3, Pax2, and Pax8 in the prospective lens, trigeminal,
profundal, epibranchial, otic, and lateral line placodes are
also strongly reduced or lost after FGF8 knockdown
(Ahrens and Schlosser, unpublished observations).
In contrast, in zebrafish, FGF8 from the prospective
hindbrain region of the neural plate has been shown to be
essential in conjunction with FGF3 for otic induction
(Phillips et al., 2001, 2004; Maroon et al., 2002; Le´ger
and Brand, 2002; Liu et al., 2003; Solomon et al., 2004) but
dispensable for the expression of panplacodal genes such as
six4.1, eya1, and dlx3 in nonotic domains (Shanmugalin-
gam et al., 2000; Le´ger and Brand, 2002; Solomon et al.,
2004). In amniotes, where FGF8 is neither expressed in the
anterior neural plate nor in the prospective hindbrain
(Crossley and Martin, 1995; Adamska et al., 2002), FGFs
other than FGF8 are likely to act as otic inducers in paraxial
mesoderm and neural plate (e.g. Ladher et al., 2000, 2005;
Wright and Mansour, 2003; Alvarez et al., 2003) even
though localised endodermal expression of FGF8 has
recently been implicated in the initiation of otic induction
(Ladher et al., 2005). Taken together, this suggests
phylogenetically flexible roles of FGFs during placode
induction. While neurally derived FGF8 in zebrafish and
endodermally derived FGF8 plus other FGFs from meso-
derm and neural plate in amniotes are specifically required
for otic induction, an FGF specifically involved in otic
induction has not yet been identified in amphibians. FGF8
in Xenopus instead has a more general function in generic
placodal induction. We suggest that other FGF family
members than FGF8 may substitute for this role in generic
placode induction in amniotes and teleosts, but this remains
to be verified in future studies.
Judged by the spatiotemporal distribution of FGF8 (see
also Christen and Slack, 1997), the most likely source for
FGF8 signals involved in generic placode induction in
Xenopus is the developing anterior neural plate. As we
show here, FGF8 is upregulated at the end of gastrulation in
dorsoanterior ectoderm, which later gives rise to the
anterior neural plate but possibly also contributes toectoderm outside of the neural plate border. The placodal
crescent of Six1 appears slightly after the upregulation of
FGF8 in ectoderm immediately rostral to this FGF8
domain. At neural plate stages, FGF8 continues to be
expressed in three domains in the anterior neural plate—
two arcs in the prospective forebrain and one domain at the
prospective midbrain–hindbrain boundary—as well as in a
crescent in nonneural ectoderm (Fig. 1). The distribution of
FGF8 in the neural plate correlates closely with the
distribution of its capacity to induce Six1 ectopically
(present in central anterior neural plate and anterior neural
ridge, but absent from lateralmost anterior neural plate and
posterior neural plate; see Fig. 1P). Although neural FGF8
signals continue to be present after neural tube closure, we
observed a decline of Six1 induction when ectoderm was
grafted into the pre-placodal region at late neural fold
stages. This may indicate that FGF8 signals travel mainly in
the plane of the ectoderm, which becomes impossible with
neural tube closure. This hypothesis predicts that neural
tubes implanted under belly ectoderm should be unable to
induce ectopic Six1 expression, which should be tested in
future studies.
Loss of function experiments also support a central role
of the anterior neural plate as major source of FGF8 signals
involved in Six1 induction. Blocking FGF signalling with
SU5402 interferes with the capacity of the anterior neural
plate to induce Six1 ectopically. Moreover, extirpation of all
neural FGF8 domains by unilateral removal of the entire
anterior neural plate abolishes Six1 expression, suggesting
that continued signalling from at least some of the FGF8
signalling centers in the neural plate is required for full
determination of placodal Six1 expression. None of these
experiments can rule out an additional contribution of
nonneural FGF8 expression to placodal Six1 induction.
However, FGF8 expression in nonneural ectoderm is
apparently not able to compensate for the extirpation of
all neural FGF8 domains, probably because this nonneural
domain of FGF8 expression is itself induced directly or
indirectly by FGF8 signals from the developing neural plate
and is not yet stably determined at neural plate stages. This
interpretation is supported by our observations that FGF8
expression in nonneural ectoderm but not in the neural plate
is perturbed in FGF8 MO-injected embryos and that stage
13 nonneural ectoderm fails to maintain FGF8 expression
when grafted into the belly.
A new model for generic placode induction
Our findings provide positive evidence for the role of
FGF8 and BMP inhibitors during induction of placodal Six1
expression. However, the confinement of ectodermal Six1
induction to the anterior border of noggin- and FGF8-
injected animal caps approximately rostral to the level of the
fifth somite suggests the presence of additional signals,
which repress Six1 in the trunk. Wnts signalling through the
canonical pathway such as Wnt8 has recently been
Fig. 7. Model for generic placode induction illustrated in a schematic cross-
section through a neural plate stage Xenopus embryo. During gastrulation,
the interplay of various signalling molecules including FGFs, Wnts, BMPs,
and their antagonists (Wilson and Edlund, 2001; Niehrs, 2004; De Robertis
and Kuroda, 2004) establishes a border between a dorsal (blue) and a
ventral (green) ectodermal domain (with low BMP levels being ultimately
required for stabilising the dorsal ectodermal domain). These two
ectodermal domains have neural and epidermal default fate, respectively,
and differ in competence. The dorsal ectoderm is competent for adopting
neural or neural crest fates, and the ventral ectoderm is competent to adopt
epidermal or placodal fates. Whereas signals from the prospective
epidermis (green broken arrow) and paraxial mesoderm (orange broken
arrow) including Wnts and FGFs then induce neural crest (pink) at the
border of the neural/neural crest competence region at the end of
gastrulation, FGF8 signals from the neural plate (blue arrow) induce
generic placodal markers such as Six1 and Eya1 (red) at the border of the
epidermal/placodal competence region at neural plate/fold stages. The
dorsoventral extent of generic placode induction is probably restricted to a
region receiving permissive signals from the neural plate itself (blue arrow)
as well as from the underlying endomesoderm (maroon arrows), which
inhibit BMPs and probably Wnts, while its posterior limit may be imposed
by repressive signals confined to the trunk (orange bars) such as Wnt8.
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(Brugmann et al., 2004; Litsiou et al., 2005) suggesting that
Wnt inhibitors from cranial dorsolateral endomesoderm or
anterior neural plate (reviewed in Wilson and Edlund, 2001;
Yanfeng et al., 2003; Niehrs, 2004) contribute to placodal
Six1 induction. The expression of diffusible Wnt inhibitors
in the Xenopus anterior neural plate (Pera and De Robertis,
2000; Bradley et al., 2000) may also account for its capacity
to induce Six1 in belly ectoderm posterior to the fifth somite
and thus posterior to the level of Six1 induction observed
around FGF8- and noggin-injected animal caps. A recent
study in the chick confirms this three signal model by
showing induction of another panplacodal marker (Six4) by
FGF8 in synergy with inhibitors of BMP and Wnt signalling
(Litsiou et al., 2005), even though sustained FGF signalling
appears to be required only for Eya2 but not for Six4
induction in the chick.
In conclusion, our results suggest that FGF8—probably
from the anterior neural plate—induces placodal Six1
expression in competent nonneural ectoderm that receivesBMP inhibiting signals possibly from the underlying
endomesoderm and/or the neural plate itself. Other studies
indicate an additional role for Wnt antagonists in cranial
Six1 induction, while canonical Wnt signals may prevent
Six1 induction in the trunk. In contrast, neural crest is
induced during gastrulation in competent neuralised ecto-
derm by signals (including Wnts and FGFs) from epidermis
and paraxial mesoderm. We, therefore, propose a new model
of generic placode induction, in which the stereotypical
positioning of neural plate, neural crest, placodes, and
epidermis is explained by a sequence of distinct inductive
events (Fig. 7) rather than by different threshold responses
to a simple morphogen gradient (Sasai and De Robertis,
1997; Mayor and Aybar, 2001; Glavic et al., 2004;
Brugmann et al., 2004) or the sequential action of a com-
mon inducer on ectoderm of changing competence (Nieuw-
koop et al., 1985; Albers, 1987).Acknowledgments
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